Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report (Q40677653)
Jump to navigation
Jump to search
scientific article published on November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report |
scientific article published on November 1995 |
Statements
1 reference
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report (English)
1 reference
Zaniboni A
1 reference
Barni S
1 reference
Labianca R
1 reference
Marini G
1 reference
Pancera G
1 reference
Giaccon G
1 reference
Piazza E
1 reference
Signaroldi A
1 reference
Legnani W
1 reference
Luporini G
1 reference
1 November 1995
1 reference
1 reference
76
1 reference
10
1 reference
1694-1699
1 reference
Identifiers
1 reference
1 reference